Abstract
Abortion for first-trimester rubella soon will no longer be considered. Why? Because the live attenuated virus vaccines now available will provide long-term immunity against rubella. Even now such abortions should be rare. Only 10 to 15 percent of pregnant women are susceptible to rubella. If a patient has demonstrable antibody on a hemagglutination inhibition test, there is no risk of maternal or fetal infection.
Additional information
Notes on contributors
Alex Barno
Dr. Barno is clinical associate professor of obstetrics and gynecology, University of Minnesota Medical School, and chairman, department of obstetrics and gynecology, St. Louis Park Medical Center, Minneapolis.